| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972999 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
DZM is a safe component of induction therapy in lung transplantation. In addition, DZM may prolong freedom from acute rejection. Significant infections were more frequent in the DZM group, but this was likely due to a higher incidence of CMV mismatch. Both methods of induction therapy worked well, with excellent 1-year survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
John C. MD, Antigone MSc, Dale C. MD, Michael J. BSc, Dennis L. MD, Ken MD, Timothy L. MD, Kathy BNSc, Karen MD, Jutta MD, Phil F. MD,